Not a good buy right now for an impatient entry: the broader technical setup is still bearish (downtrend intact) and there are no near-term catalysts or proprietary buy signals.
If already holding, this looks more like a wait-for-confirmation bounce candidate near support than a high-conviction entry today.
Technical Analysis
Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating price is aligned in a multi-timeframe downtrend.
Momentum: MACD histogram at -0.0257 and negatively expanding → downside momentum is still strengthening, not stabilizing.
RSI (6): 31.5 → approaching oversold conditions, which can support a short-term bounce, but it’s not a confirmed reversal signal by itself.
Key levels:
Current pre-market: 10.83
Support: S1 10.599, then S2 10.002 (a break below S1 increases risk of a move toward ~10.00)
Resistance: Pivot 11.566, then R1 12.533 (price remains technically weak while below the pivot)
Pattern-based expectation (similar candlestick analogs): modest upside probabilities (+0.3% next day, +1.12% next week), but the edge is small versus the active downtrend.
Positive Catalysts
suggests demand is holding up (+10.99% YoY).
can enable a technical bounce if buyers defend the level.
Neutral/Negative Catalysts
Downtrend remains intact (bearish moving averages + deteriorating MACD), reducing the odds of a sustained rally without a catalyst.
Profitability deterioration: latest quarter shows a net loss and weaker EPS, which can cap valuation expansion.
No news catalysts in the past week; absent event-driven momentum, the stock may continue to drift with technical pressure.
If price loses 10.599 (S1), the next notable downside reference is ~10.00 (S2).
Gross margin: 36.55 (+28.74% YoY) → strong improvement, but not yet translating into bottom-line strength.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating / price target change data was provided, so recent Wall Street revisions can’t be confirmed.
Pros (what Wall St would likely like, based on provided data): improving revenue and notably higher gross margin.
Cons (what Wall St would likely dislike): net loss / EPS deterioration and a clearly bearish technical setup, which typically delays upgrades and target raises.
Influential trading check: No recent congress trading data available; hedge fund and insider activity reported as neutral with no significant recent trends.
Wall Street analysts forecast CSPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CSPI is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast CSPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CSPI is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
